AbbVie Deutschland GmbH & Co. KG
17 products tracked · names used in filings: AbbVie Deutschland GmbH & Co. KG
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Durysta bimatoprost | Application withdrawn | |
| 🇪🇺 | Elahere mirvetuximab soravtansine | Authorised | 2024-11-14 |
| 🇪🇺 | Tepkinly epcoritamab | Authorised | 2023-09-22 |
| 🇪🇺 | Aquipta atogepant | Authorised | 2023-08-11 |
| 🇪🇺 | Rinvoq upadacitinib | Authorised | 2019-12-16 |
| 🇪🇺 | Skyrizi risankizumab | Authorised | 2019-04-26 |
| 🇪🇺 | Maviret glecaprevir;pibrentasvir | Authorised | 2017-07-26 |
| 🇪🇺 | Venclyxto venetoclax | Authorised | 2016-12-04 |
| 🇪🇺 | Xydalba dalbavancin | Authorised | 2015-02-19 |
| 🇪🇺 | Viekirax ombitasvir;paritaprevir;ritonavir | Withdrawn | 2015-01-14 |
| 🇪🇺 | Constella linaclotide | Authorised | 2012-11-26 |
| 🇪🇺 | Ozurdex dexamethasone | Authorised | 2010-07-26 |
| 🇪🇺 | Ganfort bimatoprost;timolol | Authorised | 2006-05-19 |
| 🇪🇺 | Humira adalimumab | Authorised | 2003-09-08 |
| 🇪🇺 | Lumigan bimatoprost | Authorised | 2002-03-08 |
| 🇪🇺 | Kaletra lopinavir;ritonavir | Authorised | 2001-03-19 |
| 🇪🇺 | Norvir ritonavir | Authorised | 1996-08-25 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.